Let's talk medical research

Celebrating its 12th successful conference, SCOPE Summit 2021 took place from March 2-4, 2021. Like most events during the COVID-19 pandemic, this year’s summit was fully virtual. During these unprecedented times, the work that the clinical research community does is more important than ever, and requires collaboration and innovation. Antidote’s Dave Mauro, Executive Vice President of Business ...

When your COPD symptoms suddenly worsen, you may think you’re just having a really bad breathing day. This might, however, mean you’re having an exacerbation. A COPD exacerbation, also known as a COPD flare-up or episode, occurs when your COPD symptoms get worse than usual and may continue to get worse without extra treatment. The average annual rate of exacerbations in COPD patients is between ...

It's no secret that it's very expensive to bring a new drug to market. According to a recent analysis published in JAMA, U.S. biopharmaceutical companies spent about $1 billion to bring each of their new drugs to market between 2009 and 2018. Other studies estimate that a drug can cost up to $2.8 billion to bring to market. In 2019, research and development spending in the pharmaceutical industry ...

In order to reach patients, every potential medical intervention must make its way through a rigorous approval process, passing through clinical trial phases. Each clinical trial phase has a different goal and separate hurdles to clear before a potential new treatment or medical device can move forward.

Inflammatory bowel disease, commonly referred to as IBD, is characterized by a group of intestinal disorders that cause inflammation of the digestive tract. Approximately 1.6 million Americans currently have IBD, and that number may be growing. The two most common kinds of IBD are ulcerative colitis (UC) and Crohn’s disease. Every person’s experience with IBD is different, but some of the more ...

What impact has COVID-19 had on our collective mental health? How has treatment been adapted to meet new needs? And what does this all mean for clinical trial participants?

Patient centricity is a phrase that generates a lot of buzz in the clinical research community — it typically refers to designing a treatment, clinical trial, or other health solution around patients’ needs and perspectives. Creating a patient-centric solution involves getting feedback from advocacy groups and patients themselves, and making decisions based on their voices. At the heart of it, ...

Hepatitis B (HBV) is one of the most serious liver infections in the world. Untreated hepatitis B can cause fibrosis, cirrhosis, hepatocellular carcinoma, and end-stage liver disease. Doctors run several blood tests to see if the infection is harming your liver and to identify what stage of infection you are in. Here’s why one of those blood tests — the HBV DNA (viral load test) — matters and ...

When creating clinical trial advertising materials, it's important to craft outreach copy that connects with patients and care partners. But in order for your Institutional Review Board (IRB) to approve your materials, they must also adhere to guidelines set out by the Food and Drug Administration (FDA).

Clinical trials can't move forward without volunteers, but sometimes, clinical trial volunteers have trouble getting to trial sites. This is especially true during a pandemic, where safety needs to be top of mind. One survey about clinical trial participation barriers revealed that the number one reason for declining to participate in a trial is the inconvenience of travel, cited by 42% of ...